Yu Xiong Selected Research

Yu Xiong Research Topics

Disease

34	Neoplasms (Cancer) 05/2024 - 08/2009
14	Pre-Eclampsia (Preeclampsia) 10/2023 - 06/2010
6	Hepatocellular Carcinoma (Hepatoma) 05/2024 - 01/2012
6	Glioma (Gliomas) 08/2023 - 01/2018
5	Neoplasm Metastasis (Metastasis) 04/2024 - 12/2018
4	Osteoporosis 04/2024 - 07/2007
4	Human Influenza (Influenza) 01/2024 - 04/2019
4	Hypoxia (Hypoxemia) 01/2023 - 10/2008
4	Inflammation (Inflammations) 01/2023 - 11/2019
4	Leiomyoma (Uterine Fibroids) 01/2023 - 12/2012
3	Breast Neoplasms (Breast Cancer) 04/2024 - 01/2019
3	Carcinogenesis 04/2024 - 01/2022
3	Hypertension (High Blood Pressure) 12/2022 - 06/2014
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2022 - 10/2021
3	Retinal Neovascularization 01/2022 - 10/2008
3	Hyperplasia 01/2022 - 07/2007
3	Atrophy 01/2022 - 01/2019
3	Fibrosis (Cirrhosis) 01/2022 - 01/2022
3	Necrosis 01/2022 - 04/2016
3	Pain (Aches) 01/2021 - 06/2010
3	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2021 - 01/2019
2	COVID-19 04/2024 - 01/2023
2	Ischemic Stroke 03/2024 - 11/2019
2	Infections 01/2024 - 09/2022
2	Hypothyroidism 10/2023 - 01/2023
2	Graft vs Host Disease (Graft-Versus-Host Disease) 08/2023 - 01/2023
2	Carcinoma (Carcinomatosis) 02/2023 - 01/2023
2	Premature Birth (Birth, Premature) 01/2023 - 01/2021
2	Cognitive Dysfunction 01/2023 - 11/2021
2	Stroke (Strokes) 01/2023 - 12/2022
2	Type 2 Diabetes Mellitus (MODY) 01/2023 - 01/2012
2	Hematoma 01/2023 - 01/2023
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2022 - 01/2022
2	Cerebral Hemorrhage 01/2022 - 11/2019
2	Chronic Renal Insufficiency 01/2022 - 01/2022
2	Hyperglycemia 01/2022 - 01/2021
2	Melanoma (Melanoma, Malignant) 01/2022 - 01/2019
2	Leukemia 01/2022 - 01/2021
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 12/2021
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 05/2021 - 01/2021
2	Leiomyomatosis 01/2020 - 11/2015
2	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 12/2014
2	Retinal Degeneration 01/2019 - 12/2016
2	Postpartum Hemorrhage 01/2019 - 06/2010
2	Hematologic Neoplasms (Hematological Malignancy) 12/2018 - 10/2015

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 10/2022 - 05/2006
7	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2019
7	Long Noncoding RNAIBA 09/2023 - 01/2018
6	Messenger RNA (mRNA)IBA 02/2023 - 12/2015
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 10/2008
5	RNA (Ribonucleic Acid)IBA 01/2024 - 10/2008
4	VaccinesIBA 04/2024 - 12/2021
3	CateninsIBA 12/2023 - 01/2022
3	AntigensIBA 01/2022 - 11/2009
3	Therapeutic UsesIBA 01/2022 - 11/2019
3	Small Interfering RNA (siRNA)IBA 08/2009 - 10/2008
2	BerberineIBA 05/2024 - 11/2021
2	CalciumIBA 04/2024 - 11/2022
2	Peptides (Polypeptides)IBA 04/2024 - 07/2007
2	Cell-Free Nucleic AcidsIBA 01/2024 - 01/2019
2	CytokinesIBA 01/2024 - 06/2023
2	ChemokinesIBA 01/2024 - 06/2023
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2024 - 09/2022
2	Thyroxine (Levothyroxine)FDA LinkGeneric 10/2023 - 01/2023
2	DNA (Deoxyribonucleic Acid)IBA 06/2023 - 01/2019
2	perfluorooctaneIBA 01/2023 - 12/2022
2	MicroRNAs (MicroRNA)IBA 01/2023 - 01/2020
2	Retinaldehyde (Retinal)IBA 01/2023 - 01/2022
2	FluorocarbonsIBA 12/2022 - 10/2020
2	CollagenIBA 12/2022 - 01/2022
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2022 - 01/2022
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2022 - 01/2009
2	Adenosine (Adenocard)FDA LinkGeneric 10/2022 - 01/2022
2	Huang QiIBA 01/2022 - 01/2022
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2021
2	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2022 - 12/2021
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2020
2	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2022 - 12/2021
2	ErbB Receptors (EGF Receptor)IBA 01/2022 - 01/2016
2	Urea (Carbamide)FDA LinkGeneric 01/2022 - 09/2016
2	Protein Kinases (Protein Kinase)IBA 03/2019 - 12/2018
2	AminesIBA 03/2019 - 12/2018
2	bisphenol AIBA 01/2019 - 12/2017
2	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 01/2019 - 12/2016
2	tissue-factor-pathway inhibitor 2 (PP5)IBA 04/2017 - 06/2010
2	SurvivinIBA 01/2016 - 08/2009
2	Estrogens (Estrogen)FDA Link 12/2015 - 07/2007
2	Contrast MediaIBA 04/2015 - 12/2012
2	contrast agent BR1IBA 04/2015 - 12/2012
2	Thromboplastin (Tissue Factor)IBA 01/2011 - 06/2010

Therapy/Procedure

16	Therapeutics 05/2024 - 07/2007
8	Immunotherapy 01/2024 - 10/2015
8	Drug Therapy (Chemotherapy) 03/2023 - 03/2014
4	Radiotherapy 03/2023 - 01/2021
3	Hematopoietic Stem Cell Transplantation 08/2023 - 10/2015
2	Punctures 01/2024 - 01/2023
2	Lasers (Laser) 01/2022 - 06/2014
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 12/2021
2	Lymphatic Irradiation 01/2021 - 12/2018
2	High-Intensity Focused Ultrasound Ablation 11/2015 - 01/2015